金红片在正常大鼠、慢性浅表性胃炎大鼠及肠道微生物紊乱大鼠中的药代动力学特性
Pharmacokinetic characteristics of Jinhong tablets in normal, chronic superficial gastritis and intestinal microbial disorder rats
摘要 Abstract
金红片(JHT)是一种由四种草药制成的传统中药,通过疏肝解郁、调理气机、活血化瘀等功效有效治疗慢性浅表性胃炎(CSG)。然而,其药代动力学特征尚未充分研究。本研究探讨了正常大鼠中JHT的药代动力学特征及其在正常大鼠、CSG大鼠以及肠道微生物紊乱大鼠中的差异。采用UPLC-TQ-MS/MS建立了检测大鼠血浆中七种活性成分的定量方法。通过对不同剂量JHT给药后的大鼠血浆浓度进行测定,评估了正常大鼠中的药代动力学特征。比较了正常大鼠、CSG大鼠以及粪便微生物移植(FMT)大鼠中四种主要成分的药代动力学特征,并通过高通量测序评估了肠道微生物的变化。采用Spearman相关分析关联了成分暴露与肠道微生物群紊乱的关系。该方法表现出良好的线性、精密度、准确度、提取回收率和稳定性。在正常大鼠中,七种成分均迅速被吸收,其中四氢巴马汀、小檗碱、去氢延胡索甲素和七叶苷具有较好的暴露量,而四氢掌叶防己碱、异紫堇品啶和盐酸巴马汀的暴露量较低。四氢巴马汀、小檗碱和去氢延胡索甲素在剂量为0.7-5.6 g/kg时呈现线性药代动力学特征(AUC0-t、Cmax),而七叶苷和去氢延胡索甲素在剂量为0.7-2.8 g/kg时表现出线性。在CSG和FMT大鼠中观察到药代动力学差异。CSG增强了去氢延胡索甲素的暴露量和Cmax,增加了七叶苷的暴露量。FMT提高了小檗碱的暴露量和七叶苷的Cmax,这与20个细菌属有关。
Jinhong tablet (JHT), a traditional Chinese medicine made from four herbs, effectively treats chronic superficial gastritis (CSG) by soothing the liver, relieving depression, regulating qi, and promoting blood circulation. However, its pharmacokinetics are underexplored. This study investigates JHT's pharmacokinetics in normal rats and its differences in normal, CSG, and intestinal microbial disorder rats. A quantitative method for seven active ingredients in rat plasma was established using UPLC-TQ-MS/MS. After administering various JHT doses, plasma concentrations were measured to assess pharmacokinetics in normal rats. The pharmacokinetics of four main ingredients were compared in normal, CSG, and fecal microbiota transplantation (FMT) rats. Intestinal microbial changes were evaluated by high-throughput sequencing. Spearman correlation analysis linked ingredient exposure to gut microbiota disturbances. The method showed good linearity, precision, accuracy, extraction recovery, and stability. In normal rats, all seven ingredients were rapidly absorbed. Tetrahydropalmatine, corydaline, costunolide, and rhamnosylvitexin had good exposure, while dehydrocorydaline, allocryptopine, and palmatine hydrochloride had low exposure. Tetrahydropalmatine, corydaline, and costunolide followed linear pharmacokinetics (AUC0-t, Cmax) at doses of 0.7-5.6 g/kg, while rhamnosylvitexin and dehydrocorydaline showed linearity at 0.7-2.8 g/kg. In CSG and FMT rats, pharmacokinetic differences were observed. CSG enhanced costunolide exposure and Cmax, and increased rhamnosylvitexin exposure. FMT raised corydaline exposure and rhamnosylvitexin Cmax, linked to 20 bacterial genera.